908 Devices Inc
$ 6.79
4.62%
24 Feb - close price
- Market Cap 234,892,000 USD
- Current Price $ 6.79
- High / Low $ 6.92 / 6.39
- Stock P/E N/A
- Book Value 3.77
- EPS -2.07
- Next Earning Report 2026-03-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.16 %
- ROE -0.54 %
- 52 Week High 9.34
- 52 Week Low 1.92
About
908 Devices Inc. develops and sells measuring devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Boston, Massachusetts.
Analyst Target Price
$10.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-10 | 2025-08-05 | 2025-04-28 | 2025-03-03 | 2024-11-12 | 2024-08-06 | 2024-04-30 | 2024-03-05 | 2023-11-07 | 2023-08-08 | 2023-05-09 | 2023-03-07 |
| Reported EPS | -0.41 | -0.36 | -0.1867 | -0.2803 | -0.845 | -0.31 | -0.33 | -0.23 | -0.22 | -0.29 | -0.39 | -0.31 |
| Estimated EPS | -0.14 | -0.17 | -0.36 | -0.3467 | -0.28 | -0.33 | -0.36 | -0.26 | -0.3 | -0.35 | -0.35 | -0.26 |
| Surprise | -0.27 | -0.19 | 0.1733 | 0.0664 | -0.565 | 0.02 | 0.03 | 0.03 | 0.08 | 0.06 | -0.04 | -0.05 |
| Surprise Percentage | -192.8571% | -111.7647% | 48.1389% | 19.152% | -201.7857% | 6.0606% | 8.3333% | 11.5385% | 26.6667% | 17.1429% | -11.4286% | -19.2308% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-03 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.06 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MASS
2026-02-18 06:02:35
908 Devices Inc. (Nasdaq: MASS) announced it will report its financial results for the fourth quarter and full year 2025 before market open on Tuesday, March 3, 2026. Following the release, company management will host a conference call webcast at 8:30 a.m. Eastern Time. The webcast will be accessible through the "Investors" section of the company's website and will be archived for replay.
2026-02-17 11:58:05
908 Devices Inc. (Nasdaq: MASS) announced it will release its financial results for the fourth quarter and full year 2025 before the market opens on Tuesday, March 3, 2026. Management will host a webcast conference call at 8:30 a.m. Eastern Time, accessible via the "Investors" section of their website. The company specializes in handheld chemical analysis tools for health, safety, and defense applications.
2026-02-13 17:58:03
908 Devices has launched its new MX908 device, designed to improve chemical identification for faster and more secure decision-making. This product provides clear chemical analysis, which is crucial for investigations and legal prosecutions. The company highlights the MX908's reliability in results, aligning with its commitment to advanced corrections technology and trace detection for enhanced facility safety.
2026-02-08 01:38:05
908 Devices delivered a strong financial performance in 2025, with revenue reaching $56.0 million, exceeding projections. The company also rolled out significant software upgrades for its MX908 mass spectrometer, enhancing its chemical analysis capabilities for first responders. The market for portable mass spectrometry is expected to grow significantly, with 908 Devices well-positioned to capitalize on this trend.
2026-02-05 16:59:21
908 Devices Inc. has released new enhancements for its MX908 mass spectrometry device, improving usability and expanding its drug detection capabilities. The updates include a new TIC (toxic industrial chemical) Hunter mission mode for hazardous vapor sampling and the addition of five priority drug targets, such as medetomidine ("rhino tranq"), N-isopropyl butylone, ADB-PINACA, MDMB-BINACA, and Bromazolam. These enhancements aim to provide first responders with faster and more reliable chemical identification for critical decision-making in evolving threat landscapes.
2026-02-04 04:58:46
Joseph H. Griffith IV, CFO of 908 Devices Inc. (NASDAQ:MASS), sold 23,175 shares for approximately $143,221 on February 2, 2026. This transaction occurred shortly after he acquired 70,035 shares through Restricted Stock Units on February 1, 2026, and despite the stock showing a significant 171.73% return over the past year. InvestingPro analysis suggests the stock is undervalued, and the company maintains a strong financial position with more cash than debt.
